Church & Dwight Q3 2026: Organic Growth of 5.1% Tops Its Own Guidance
As seen on the 24/7 Wall St. homepage on October 30, 2026.
Organic sales rose 5.1%, past the company's own 3% guide, and management lifted the full-year organic outlook and authorized a new buyback. Divestitures masked that strength at the reported line, which is why the headline growth looks flat.
Continue ReadingShow less
Church & Dwight delivered adjusted EPS of $0.92, beating expectations, even as reported revenue growth looked nearly flat year over year for a reason management was quick to address.
Organic sales rose 5.1%, well past the company's own 3% guidance heading into the quarter, driven mostly by volume. The reported line was held back by divestitures tied to the company's 2025 portfolio restructuring, including its exit from the VMS business.
Gross margin expanded 170 basis points, helped by volume leverage, productivity gains, tariff refunds, and favorable acquisition mix. Operating income and net income both rose by double digits, giving investors a cleaner read on underlying earnings power once the portfolio cleanup noise is stripped away.
Sponsored
Management raised full-year organic sales growth guidance to approximately 5% and tightened adjusted EPS growth to 7%. The board also authorized a new $1 billion share repurchase program with no expiration date, replacing the existing one.
CEO Rick Dierker flagged that inflationary pressures tied to the Middle East conflict and rising global transportation rates remain live risks, but said the company is confident it can continue to offset those costs. A formal update on 2030 growth initiatives, focused on ARM and HAMMER, THERABREATH, and the international business, is planned for a January investor meeting.
Mentioned: CHD